Selina Bannoo

Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial

Sean Kehoe, Jane Hook, Matthew Nankivell et al. · The Lancet · 2015 · 1.4K citations

Gynecologic Surgery, Surgical Oncology, Gynecological Surgery +12

Cholangiocarcinoma and dominant strictures in patients with primary sclerosing cholangitis

Michael H. Chapman, George Webster, Selina Bannoo et al. · European Journal of Gastroenterology & Hepatology · 2012 · 200 citations · Full text

Molecular Bacterial Load Assay, a Culture-Free Biomarker for Rapid and Accurate Quantification of Sputum Mycobacterium tuberculosis Bacillary Load during Treatment

Isobella Honeyborne, Timothy D. McHugh, Patrick Phillips et al. · Journal of Clinical Microbiology · 2011 · 120 citations · Full text

Culture-free Biomarker, Engineering, Bacteriology +19

Chemotherapy or upfront surgery for newly diagnosed advanced ovarian cancer: Results from the MRC CHORUS trial.

Sean Kehoe, Jane Hook, Matthew Nankivell et al. · Journal of Clinical Oncology · 2013 · 88 citations

Surgical Oncology, Cancer Management, Gynecology +22

The Combination of Circulating Ang1 and Tie2 Levels Predicts Progression-Free Survival Advantage in Bevacizumab-Treated Patients with Ovarian Cancer

Alison Backen, Andrew G. Renehan, Andrew R. Clamp et al. · Clinical Cancer Research · 2014 · 71 citations · Full text